Popular Articles

Nanobiotix Reports Exciting Preclinical Results Using Its NanoXray™ Therapeutics Technology To Destroy Tumors
Nanobiotix, an emerging nanomedicine company, announced exciting preclinical results using its patented nanoXray therapeutics platform to fight tumors. The preclinical study, performed at Institut Gustave Roussy, one of Europe"s leading cancer treatment centers, showed that an intratumoral injection of NBTXR3 nanoparticles and activated via standard radiation therapy led to complete tumor regression in mice at 60 days, compared to zero tumor regression in mice treated with xray only or NBTXR3 only. The study was led by principal investigator, Jean Bourhis, M.D., Ph.D. a prominent radiation oncologist and researcher at Institut Gustave Roussy.
generic viagra online
Obama Issues Directive To Enact New Embryonic Stem Cell Research Rules
President Obama on Thursday issued a directive to federal agencies to begin following new NIH guidelines on federally funded embryonic stem cell research, Reuters/New York Times reports (Reuters/New York Times, 7/30). NIH announced the final guidelines earlier this month. The guidelines assess whether newly created embryonic stem cell lines can be used for federally funded research, as well as clarify how old lines will be evaluated (Daily Women"s Health Policy Report, 7/7).In March, Obama overturned President George W. Bush"s policy limiting federal funding of embryonic stem cell research. In a statement Thursday, Obama said, "I hereby direct the heads of executive departments and agencies that support and conduct stem cell research to adopt these guidelines, to the fullest extent practicable in light of legal authorities and obligations" (Reuters/New York Times, 7/30).
News of the day
Larvae Shun The Light
Drosophila larvae avoid light during the foraging stage of their development. Research published in the open access journal BMC Neuroscience shows that both 5-HT (serotonergic) and corazonergic neurons have a role in regulating this behavior.
Medical Devices

HCL Welcomes Government Proposals For More Flexible NHS, UK

HCL plc, the UK"s largest health and social care recruitment agency, said the Government"s proposals to reform the NHS by devolving power to frontline professionals and patients will mean a greater need for flexible staffing and more collaboration between the public and private sectors. The Government strategy document "Building Britain"s Future", outlines proposals to reduce bureaucracy in the NHS and give patients enforceable rights to high standards of care. The proposals include Personal Health Budgets, faster access to hospital treatment and "clear redress mechanisms" if those entitlements were not met - including the right to request an immediate appointment at another hospital if their local one has no capacity. HCL said that these measures will make it harder for hospital managers to plan patient numbers month on month and thus lead to greater flexible staffing requirements as hospitals need to staff up and staff down quickly to cope with greater patient churn. Kate Bleasdale, Executive Vice Chairman of HCL, said: "We welcome a move away from the top down targets culture to a culture of entitlement that gives more power to frontline professionals. These new proposals pave the way for a more innovative and collaborative partnership between the public and private sectors, particularly in staffing where it is important to maintain the right balance of permanent and flexible healthcare staff to meet the fluctuating needs of the local population. "HCL has close and long-standing relationships with many of the UK"s leading hospitals and we understand that each one"s culture and needs are different. We are committed to working hand in hand with NHS Trusts to ensure that their staffing needs continue to be met, to help them achieve greater efficiency and most importantly ensure faster treatment and better outcomes for patients." HCL plc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):